BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11469683)

  • 21. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
    Geum D; Sun W; Paik SK; Lee CC; Kim K
    Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective usage of D-type cyclins in lymphoid malignancies.
    Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
    Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines.
    Ullmannová V; Stöckbauer P; Hradcová M; Soucek J; Haskovec C
    Leuk Res; 2003 Dec; 27(12):1115-23. PubMed ID: 12921950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cyclin D2 and D3 in lymphoid lesions.
    Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
    Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression.
    Poch B; Gansauge F; Schwarz A; Seufferlein T; Schnelldorfer T; Ramadani M; Beger HG; Gansauge S
    Pancreas; 2001 Oct; 23(3):280-7. PubMed ID: 11590324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
    Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
    In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo.
    Sun W; Lee DK; Lee CC; Kim K
    Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells.
    Wagner M; Weber CK; Bressau F; Greten FR; Stagge V; Ebert M; Leach SD; Adler G; Schmid RM
    Gastroenterology; 2002 Jun; 122(7):1898-912. PubMed ID: 12055597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture.
    Kawada N; Ikeda K; Seki S; Kuroki T
    J Hepatol; 1999 Jun; 30(6):1057-64. PubMed ID: 10406184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
    Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
    Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis.
    Damstrup L; Kuwada SK; Dempsey PJ; Brown CL; Hawkey CJ; Poulsen HS; Wiley HS; Coffey RJ
    Br J Cancer; 1999 Jun; 80(7):1012-9. PubMed ID: 10362109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
    Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR
    Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abundance and subcellular localisation of cyclin D3 in human tumours.
    Bartkova J; Zemanova M; Bartek J
    Int J Cancer; 1996 Jan; 65(3):323-7. PubMed ID: 8575852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D2 expression in familial and sporadic breast cancer.
    Fischer H; Chen J; Skoog L; Lindblom A
    Oncol Rep; 2002; 9(6):1157-61. PubMed ID: 12375011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
    Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH
    Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unscheduled expression of cyclins D1 and D3 in human tumour cell lines.
    Juan G; Gong J; Traganos F; Darzynkiewicz Z
    Cell Prolif; 1996 May; 29(5):259-66. PubMed ID: 8782488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.
    Liu N; Furukawa T; Kobari M; Tsao MS
    Am J Pathol; 1998 Jul; 153(1):263-9. PubMed ID: 9665487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary fibroblasts stimulate the proliferation of cell lines from human lung adenocarcinomas.
    Cekanova M; Masi T; Plummer HK; Majidi M; Fedorocko P; Schuller HM
    Anticancer Drugs; 2006 Aug; 17(7):771-81. PubMed ID: 16926627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.